Factor VII deficiency, although rare, is now recognized as the most common autosomal recessive inherited factor deficiency. It is usually considered to be associated with bleeding only in the severely affected subject and heterozygotes (>10%) are not considered at risk. The general recommendation fo
β¦ LIBER β¦
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor vii deficiency
β Scribed by Stephen E. Doran; Thomas R. Henry; Paula L. Bockenstedt; Donald A. Ross
- Book ID
- 119041904
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 322 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0090-3019
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lack of bleeding in patients with severe
β
J. Mark Barnett; Kurt C. Demel; Anthony E. Mega; James N. Butera; Joseph D. Swee
π
Article
π
2005
π
John Wiley and Sons
π
English
β 120 KB
π 2 views
Long-term follow-up of prophylaxis with
β
B. JENABALI JAHROMI; M. KARIMI
π
Article
π
2011
π
John Wiley and Sons
π
English
β 150 KB
Prophylaxis and therapy with factor VII
β
Lewis J. Cohen; Nancy B. McWilliams; Ronnie Neuberg; William Zinkham; Kenneth Ba
π
Article
π
1995
π
John Wiley and Sons
π
English
β 754 KB
M.D.P.); and lmmuno A.G., Vienna, Austria (M.K.) Hereditary factor VII deficiency is a rare autosomal recessive condition, usually associated with normal or reduced levels of a functionally defective molecule. The available means of treating thiscondition in North America presents serious health ri
What dose of recombinant activated facto
β
S. A. Brown
π
Article
π
2005
π
John Wiley and Sons
π
English
β 32 KB
A retrospective analysis of 157 surgical
β
F. BENLAKHAL; T. MURA; J.-F. SCHVED; M. GIANSILY-BLAIZOT; ON BEHALF OF THE FRENC
π
Article
π
2011
π
John Wiley and Sons
π
English
β 204 KB
The use of activated recombinant coagula
β
R. GonzΓ‘lez-Boullosa; R. Ocampo-MartΓnez; M. J. AlarcΓ³n-MartΓn; M. SuΓ‘rez-RodrΓg
π
Article
π
2005
π
John Wiley and Sons
π
English
β 52 KB